(Photo: adapted from Charles Williams/flickr)
Apr 25, 2013
As many as 2,600 "human guinea pigs" died in the past seven years during drug trials by foreign pharmaceutical corporations, The Times of India reports on Thursday.
Trials for two drugs by pharma giants Bayer and Novartis "accounted for maximum number of deaths," they report.
"Serious adverse events of deaths during the clinical trials during the said period were 2,644, out of which 80 deaths were found to be attributable to the clinical trials," health secretary Keshav Desiraju said in an affidavit on behalf of the ministry of health and family welfare.
"Around 11,972 serious adverse events (excluding death) were reported during the period from January 1, 2005 to June 30, 2012, out of which 506 events were found to be related to clinical trials," he added.
According to the paper, trials of 475 drugs took place but only 17 of them were approved for marketing in India.
__________________________
Join Us: News for people demanding a better world
Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place. We're hundreds of thousands strong, but every single supporter makes the difference. Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
As many as 2,600 "human guinea pigs" died in the past seven years during drug trials by foreign pharmaceutical corporations, The Times of India reports on Thursday.
Trials for two drugs by pharma giants Bayer and Novartis "accounted for maximum number of deaths," they report.
"Serious adverse events of deaths during the clinical trials during the said period were 2,644, out of which 80 deaths were found to be attributable to the clinical trials," health secretary Keshav Desiraju said in an affidavit on behalf of the ministry of health and family welfare.
"Around 11,972 serious adverse events (excluding death) were reported during the period from January 1, 2005 to June 30, 2012, out of which 506 events were found to be related to clinical trials," he added.
According to the paper, trials of 475 drugs took place but only 17 of them were approved for marketing in India.
__________________________
As many as 2,600 "human guinea pigs" died in the past seven years during drug trials by foreign pharmaceutical corporations, The Times of India reports on Thursday.
Trials for two drugs by pharma giants Bayer and Novartis "accounted for maximum number of deaths," they report.
"Serious adverse events of deaths during the clinical trials during the said period were 2,644, out of which 80 deaths were found to be attributable to the clinical trials," health secretary Keshav Desiraju said in an affidavit on behalf of the ministry of health and family welfare.
"Around 11,972 serious adverse events (excluding death) were reported during the period from January 1, 2005 to June 30, 2012, out of which 506 events were found to be related to clinical trials," he added.
According to the paper, trials of 475 drugs took place but only 17 of them were approved for marketing in India.
__________________________
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.